Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from GSK

Time for Unilever boss to concede lack of appetite for a big tilt

Shake-up will have to be gradual, and deal-making on a smaller scale needn’t be off the table

The Guardian - UK

Top investor castigates Unilever after failed £50bn bid for GSK arm

Terry Smith says bosses must focus on improving core business or step down after ‘near-death experience’

The Guardian - UK

City comment: Unilever CEO Alan Jope is walking a tightrope after GSK tilt

Questions remain about strategy despite the GSK climbdown

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

UK households hit by rising cost of living; Omicron lifts US jobless claims to three-month high – as it happened

Rolling coverage of the latest economic and financial news

The Guardian - UK

Unilever won't up £50bn offer for GSK-Pfizer unit

LONDON: Consumer goods giant Unilever on Wednesday said it would not increase a £50-billion offer for the consumer healthcare unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer.

Bangkok Post

Unilever won't up £50 bn offer for GSK-Pfizer unit

London (AFP) - Consumer goods giant Unilever on Wednesday said it would not increase a £50-billion offer for the consumer healthcare unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer.

AFP

Big questions for Unilever board after GSK pursuit ends

Delivering a minor heart attack to the share price, however temporarily, is not a good look

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Unilever will not increase £50bn offer for GSK consumer arm

Company says data shared by GSK suggests ‘fundamental value’ of business no higher than offer

The Guardian - UK

Unilever won't top $68B bid for GSK consumer healthcare unit

Unilever, the maker of Vaseline skin care products and Dove soap, says it won’t increase a 50 billion-pound ($68.2 billion) offer for GlaxoSmithKline’s consumer healthcare unit that was rejected last week

The Independent UK

Unilever vows not to increase GSK bid

Unilever has effectively ruled out a fourth takeover approach for GlaxoSmithKline’s consumer healthcare business after vowing not to increase its offer.

Evening Standard

GSK’s top scientist jumps ship in new blow for pharmaceutical firm

Hal Barron to leave just as pressure builds on GSK to come up with new medicines

The Guardian - UK

UK inflation jumps to 30-year high of 5.4% as cost of living crisis deepens – as it happened

Food prices, furniture, clothes and housing costs rise; unions urge government to tackle cost of living crisis as pressure builds for February rate hike

The Guardian - UK

Little ingenuity needed to spot the weakness of THG

The value of the e-commerce firm’s ‘end-to-end technology solutions’ doesn’t seem clear – no wonder investors went cold

The Guardian - UK

Unilever ‘could lose credit rating’ with purchase of GSK consumer arm

Deal could swell Unilever’s debt pile, says ratings agency Fitch

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Unilever’s bid for GSK consumables isn’t quite the shocker it seems

This could be a long campaign and, despite all the difficulties, there is a logic to the proposal

Evening Standard

Unilever punished by City for failed £50bn tilt at GSK

A PROPOSED fire-sale of under-performing food assets failed to stem the blood-letting at Unilever today as the City issued a damning verdict over its failed £50 billion tilt at GlaxoSmithKline.

The Guardian - UK

Unilever to expand health and beauty business after failed GSK approach

Dove soap maker’s shares are biggest faller on FTSE 100 after offer for consumer products arm is rebuffed

AFP

Unilever pursues GSK-Pfizer unit after huge bid rebuffed

London (AFP) - Consumer goods giant Unilever on Monday said it would press on with a bid for the consumer health care unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer after an offer of £50 billion ($68 billion) was refused.

Get all your
news in one place.

100’s of premium titles.
One news app.

1 … 10 11 12 13

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.